| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1089/GTE.1997.1.35 |
| P698 | PubMed publication ID | 10464623 |
| P2093 | author name string | Chiba-Falek O | |
| Kerem B | |||
| Kerem E | |||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | cystic fibrosis | Q178194 |
| P304 | page(s) | 35-39 | |
| P577 | publication date | 1997-01-01 | |
| P1433 | published in | Genetic Testing and Molecular Biomarkers | Q15753742 |
| P1476 | title | Cystic fibrosis in Jews: frequency and mutation distribution | |
| P478 | volume | 1 |
| Q45862492 | A new era in the treatment of cystic fibrosis. |
| Q24186760 | Ataluren and similar compounds (specific therapies for premature termination codon class I mutations) for cystic fibrosis |
| Q34549637 | Ataluren and similar compounds (specific therapies for premature termination codon class I mutations) for cystic fibrosis. |
| Q28073996 | CFTR Modulators: Shedding Light on Precision Medicine for Cystic Fibrosis |
| Q37583400 | CFTR: A New Horizon in the Pathomechanism and Treatment of Pancreatitis |
| Q34283509 | Class 1 CF Mutations |
| Q33608581 | Clinical practice and genetic counseling for cystic fibrosis and CFTR-related disorders |
| Q33152916 | Clinical, genetic, and electrophysiologic characteristics of a new PAS-domain HERG mutation (M124R) causing Long QT syndrome. |
| Q93204763 | Compound heterozygous mutations in CFTR causing CBAVD in Chinese pedigrees |
| Q51424428 | Cystic Fibrosis: The Dawn of a New Therapeutic Era. |
| Q27022401 | Cystic fibrosis therapeutics: the road ahead |
| Q37164477 | Development, clinical utility, and place of ivacaftor in the treatment of cystic fibrosis |
| Q33444638 | Discovery of rare variants via sequencing: implications for the design of complex trait association studies |
| Q46415131 | Effectiveness of PTC124 treatment of cystic fibrosis caused by nonsense mutations: a prospective phase II trial |
| Q26781980 | Epidemiology and genetics of cystic fibrosis in Asia: In preparation for the next-generation treatments |
| Q79320472 | Helicobacter pylori and Clostridium difficile in cystic fibrosis patients |
| Q21184013 | Implications for health and disease in the genetic signature of the Ashkenazi Jewish population |
| Q34103034 | Meta-analyses of 4 CFTR variants associated with the risk of the congenital bilateral absence of the vas deferens |
| Q30110841 | Multiple forms of casein kinase from rabbit erythrocytes |
| Q34381743 | Replication strategies for rare variant complex trait association studies via next-generation sequencing |
Search more.